Professor
Université Paris Saclay
Chief of Cardiac and Vascular Surgery
Hôpital Marie Lannelongue, GHPSJ
Paris, France
Presenter
SESSION 1: PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE
Presenter
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, STABILISE, THORACIC AORTA AND MORE
Presenter
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAS)
Session Moderator
SESSION 43: NEW DEVELOPMENTS IN AAA BEHAVIOR, TREATMENT AND STANDARD INFRARENAL EVAR: THE INFLUENCE OF DIABETES, BLOOD PRESSURE, AGE, ETC. ON AAA GROWTH; IMPROVED ULTRASOUND SURVEILLANCE, LOCAL ANESTHESIA FOR EVAR, 3D CTA ANALYSIS, CONSEQUENCES OF AAAS LOST TO FOLLOW-UP AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
Presenter
SESSION 95: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS; DECREASING RADIATION EXPOSURE OR CONTRAST TOXICITY
SESSION 1: PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE
DEBATE: Update On Endo-Bentall Procedures For Combined Ascending Aorta And Valve Disease: Devices And Results To Date: Open Surgery Is Destined To Be Replaced
7:44 AM - 7:49 AM
Presenter
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, STABILISE, THORACIC AORTA AND MORE
Retrograde Branches For Arch Endovascular Repairs: How To Do Them Safely Totally Via Transfemoral Access Using Specialized Reinforced Variable Sheaths: Indications And Results
9:14 AM - 9:19 AM
Presenter
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAS)
The European Aortic Data Collection (EADC) Study Shows That F/B/EVAR Is The Best Treatment For Most Complex AAAs And TAAAs: When Is It Not And The Value Of A New Bridging Stent (BeFlared – Bentley) Which Flares More Easily
11:36 AM - 11:41 AM
Session Moderator
SESSION 43: NEW DEVELOPMENTS IN AAA BEHAVIOR, TREATMENT AND STANDARD INFRARENAL EVAR: THE INFLUENCE OF DIABETES, BLOOD PRESSURE, AGE, ETC. ON AAA GROWTH; IMPROVED ULTRASOUND SURVEILLANCE, LOCAL ANESTHESIA FOR EVAR, 3D CTA ANALYSIS, CONSEQUENCES OF AAAS LOST TO FOLLOW-UP AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
Presenter
SESSION 95: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS; DECREASING RADIATION EXPOSURE OR CONTRAST TOXICITY
Experience With A New Better Setup For A Hybrid OR/Suite: Features, Advantage And Cost: Who Supplies It And What Components Make A Difference For Standard And Advanced Procedures
9:58 AM - 10:03 AM